iBio Inc. (IBIO) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear

iBio Inc.

NASDAQ: IBIO · Real-Time Price · USD
0.82
0.02 (2.92%)
At close: Sep 26, 2025, 1:16 PM

iBio Income Statement

Financials in USD. Fiscal year is July - June.
Fiscal Year FY 2025 FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Jun 30, 2025 Jun 30, 2024 Jun 30, 2023 Jun 30, 2022 Jun 30, 2021
Revenue
400K 225K n/a 1.88M 2.37M
Cost of Revenue
n/a 1.25M 1.11M 216K 1.46M
Gross Profit
n/a 225K -1.11M 2.17M 909K
Operating Income
-18.38M -16.63M -29.31M -29.7M -31.11M
Interest Income
437K 363K 130K 177K 140K
Pretax Income
n/a -15.44M -29.31M -29.51M -23.21M
Net Income
n/a -24.91M -29.31M -51.01M -23.21M
Selling & General & Admin
10.69M 11.67M 18.45M 21.75M 22.03M
Research & Development
8.31M 5.18M 10.33M 9.83M 9.99M
Other Expenses
n/a n/a 565K 13K 12K
Operating Expenses
19M 16.86M 29.34M 31.36M 32.02M
Interest Expense
-212K 172K n/a n/a 2.45M
Selling & Marketing Expenses
n/a n/a n/a n/a n/a
Cost & Expenses
n/a 16.86M 29.34M 52.07M 33.48M
Income Tax Expense
n/a n/a n/a 701K 46K
Shares Outstanding (Basic)
10.5M 3.83M 1.23M 872.1K 391.24K
Shares Outstanding (Diluted)
10.5M 3.83M 1.23M 872.1K 391.24K
EPS (Basic)
-1.75 -6.5 -23.94 -58.49 -60
EPS (Diluted)
-1.75 -6.5 -23.94 -58.49 -60
EBITDA
-18.38M -14.02M -28.12M -25.72M -18.34M
EBIT
n/a -15.27M -29.23M -29.51M -20.76M
Depreciation & Amortization
n/a 1.25M 1.11M 3.79M 2.41M